Lipella Pharmaceuticals Inc. (LIPO)
OTCMKTS
· Delayed Price · Currency is USD
0.155
0.00 (0.00%)
At close: Mar 6, 2026
Lipella Pharmaceuticals Revenue
Lipella Pharmaceuticals had revenue of $389.78K in the twelve months ending September 30, 2025, down -19.39% year-over-year. In the year 2024, Lipella Pharmaceuticals had annual revenue of $536.36K with 19.29% growth.
Revenue (ttm)
389.78K
Revenue Growth
-19.39%
P/S Ratio
1.84
Revenue / Employee
64.96K
Employees
7
Market Cap
716.69K
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionLipella Pharmaceuticals News
- 6 months ago - Lipella Pharmaceuticals to Present at Zacks SCR Life Sciences Virtual Investor Forum and Report Final Phase 2a Results in Oral Lichen Planus - PRNewsWire
- 9 months ago - Lipella Pharmaceuticals Issues Letter from the CEO to Stockholders Following Nasdaq Delisting - GlobeNewsWire
- 9 months ago - Lipella Pharmaceuticals Announces Delisting from Nasdaq Capital Market - GlobeNewsWire
- 9 months ago - Lipella Pharmaceuticals Announces U.S. Patent Issuance for Diagnostic Technology - GlobeNewsWire
- 11 months ago - Lipella Pharmaceuticals Abstract on Oral Lichen Planus Treatment Accepted for Podium Presentation at 2025 AAOM/EAOM International Meeting Conference on “Global Transformation in Oral Medicine” - GlobeNewsWire
- 1 year ago - Spartan Capital Securities, LLC Announces Key February Transactions - GlobeNewsWire
- 1 year ago - Spartan Capital Securities, LLC Serves as Sole Placement Agent in Lipella Pharmaceuticals Inc.'s $3,788,000 Private Placement - GlobeNewsWire
- 1 year ago - Nano Cap Lipella Pharmaceuticals Stock Jumps On Positive Trial Data In Patients With Sore Mouth Membranes - Benzinga